London, UK (PRWEB UK) 27 August 2014 Companies in the field of synthetic biology are emerging from the laboratory and into the commercial world, revolutionising existing markets and establishing new markets. The investment team behind the Rainbow Seed Fund, a 24 million early-stage venture capital fund dedicated to kick-starting promising UK tech companies, says synthetic biology now provides an exciting investment opportunity. In the past few years, we have seen a burgeoning number of start-ups based on synthetic biology, said Rainbow Seed Fund investment manager Oliver Sexton, who recently joined the team alongside Dr Andrew Muir and Mark White. Based on world-leading research from academic institutions and blue-sky industry labs, products and platforms are being developed that offer the real potential in diverse and significant global markets. Perhaps even more exciting synthetic biology is enabling entirely new products that were simply impossible using the previous generation of biological tools. The Rainbow Seed Fund has worked with a number of partners, including the University of Warwick, to help communicate a better understanding of the field of synthetic biology. The Fund recently released the What is Synthetic Biology? video to help explain not just what synthetic biology is, but also highlight the … Continue reading →